Clinical trial
Analgesic and Appetite-stimulating Effects of Cannabigerol Administered Alone and in Combination With Delta-9-tetrahydrocannabinol
NCT04859296 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analgesic and Appetite-stimulating Effects of Cannabigerol Administered Alone and in Combination With Delta-9-tetrahydrocannabinol
- Lead sponsor
- University of California, Los Angeles
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- February 15, 2023
- Completion date
- December 4, 2026
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
abuse, drug, appetite loss, pain